Trade Mark Journal No.2026/031 31 July 2026

WO0000001568079 (5)

Office of origin: Canada

Date of International Registration:5 August 2020
Date of designation in the UK: 20 June 2026
Image for mark 1568079_TIF JAMP

Class 5
Pharmaceutical preparations, namely prescription and non-prescription pharmaceutical preparations and drugs for the treatment of respiratory system diseases and disorders, cardiovascular diseases and disorders, central nervous diseases and disorders, neurological diseases and disorders, genitourinary diseases and disorders, gynecological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, tissue diseases and disorders, skin diseases and disorders, ocular diseases and disorders, allergies, cold, cough, sinus diseases and disorders, diabetes, hypertension, sexual diseases and disorders, prostate diseases and disorders, cancer, obesity, inflammation and inflammatory diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, viral diseases and disorders, psychiatric diseases and disorders, dental and oral diseases and disorders, motion sickness, carpal tunnel syndrome and pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; natural health product preparations, namely, dietary supplements, nutritional supplements and herbal supplements namely, plants, plant material, algae and fungus extracts and isolates of the foregoing and synthetic duplicates thereof, vitamin, mineral supplements, amino acids, fatty acids, dietary fibre, probiotics dietary supplements, enzyme and protein supplements in powder, capsule, tablet and liquid form, all for maintaining brain health, for neuroprotection, for improving or preserving cognition, memory and brain function, vitamins and nutritional supplements, namely, calcium, electrolyte drinks, energy bars, energy drinks, juice drinks, lecithin, minerals, vitamins for pharmaceutical, medicinal and therapeutic use.

JAMP PHARMA CORPORATION

Representative: LAVERY, DE BILLY, LLP Isabelle Jomphe, 1 Place Ville Marie, , Suite 4000, Montréal QC H3B 4M4, CANADA